RecruitingNCT02864108
The Human Trisome Project
Research to Develop the Human Trisome Project Biobank
Sponsor
University of Colorado, Denver
Enrollment
2,500 participants
Start Date
Jul 1, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
The Human Trisome Project will significantly increase the speed of Down syndrome research and the understanding of associated medical conditions. Its biobank will provide de-identified samples to research.
Eligibility
Min Age: 6 MonthsMax Age: 89 Years
Inclusion Criteria3
- Anyone 6 months to 89 years old who:
- has Down syndrome (any type)
- does not have Down syndrome
Exclusion Criteria2
- Prisoners
- Wards of the state
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02864108
Related Trials
Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy
NCT074162011 location
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
NCT0427840451 locations
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
NCT055089717 locations
Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
NCT052317981 location
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
NCT04546399225 locations